📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
10
SUPN Latest News & AI Sentiment Analysis
0 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 5 ARTICLES
Supernus, Indivior stock jumps after all-stock deal to merge
SUPN and INDV announced an all-stock merger, triggering immediate positive price action in both equities. All-stock deals typically...
Supernus Announces Second Quarter 2026 Financial Results
Supernus Pharmaceuticals delivered a 32% revenue beat in Q2 2026, with core growth products surging 52% year-over-year to $175.7M. This...
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Supernus Pharmaceuticals (SUPN) and Indivior announced a merger creating a combined CNS biopharmaceutical entity with approximately $2.2...
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
The all-stock merger between Supernus Pharmaceuticals (SUPN) and Indivior Pharmaceuticals (INDV) represents a significant consolidation...
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
Supernus Pharmaceuticals (SUPN) announced an expanded partnership with MERGE, designating the agency as its artificial...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice